Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetic patients and a leading cause of end-stage renal disease (ESRD). Degenerative changes such as glomerular hypertrophy, hyperfiltration, widening of basement membranes, tubulointerstitial fibrosis, glomerulosclerosis and...
Main Authors: | Kumar Pasupulati Anil, Chitra P. Swathi, Reddy G. Bhanuprakash |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2016-12-01
|
Series: | Biomolecular Concepts |
Subjects: | |
Online Access: | https://doi.org/10.1515/bmc-2016-0021 |
Similar Items
-
Evaluation of Glycated Albumin and Microalbuminuria as Early Risk Markers of Nephropathy in Type 2 Diabetes Mellitus
by: Suresh Babu Kondaveeti, et al.
Published: (2013-07-01) -
The role of advanced glycation end products in patogenesis of diabetic nephropathy
by: A. O. Gavrilova, et al.
Published: (2022-01-01) -
Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients
by: Sarath Kumar Jaganathan Jaishankar, et al.
Published: (2020-02-01) -
Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01) -
Glycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs
by: Ankita Durge, et al.
Published: (2022-10-01)